High ICAM1 levels in T1D patients are associated with a relative risk of 1.67 (95 CI 0.96–2.92, P = 0.03) of developing incident sustained microalbuminuria after adjustment for baseline age, sex, duration of diabetes, and randomized treatment assignment (Lin et al., 2008). The gene discussed is ICAM1; the disease is type 1 diabetes mellitus.